Feedback / Questions
sutetinib (SZMD4) - Jiangsu Suzhong Pharma, Teligene
http://clinicaltrials.gov/ct2/show/NCT05168566
May 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next